Evidence map›Paper›PMID 34683999›Full record

ArticlePharmaceutics2021

Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free

Mitsuyoshi Yoshimoto, Yukie Yoshii, Hiroki Matsumoto, Mitsuhiro Shinada, Masashi Takahashi, Chika Igarashi, Fukiko Hihara, Tomoko Tachibana, Ayano Doi, Tatsuya Higashi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Examination of the PET in vivo generatorEuropean journal of nuclear medicine and molecular imaging · 2024
    Article
  5. Exploring the PET in vivo generatorbioRxiv : the preprint server for biology · 2024
    Article
  6. First preclinical evaluation of [EJNMMI radiopharmacy and chemistry · 2023
    Article
  7. Article
  8. Pharmaceutics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Mitsuyoshi YoshimotoDivision of Functional Imaging, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.ORCID 0000-0003-2083-9148
Yukie YoshiiNational Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Hiroki MatsumotoNational Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Mitsuhiro ShinadaNational Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Masashi TakahashiNational Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Chika IgarashiNational Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Fukiko HiharaNational Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Tomoko TachibanaNational Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Ayano DoiDivision of Functional Imaging, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.
Tatsuya HigashiNational Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Hirofumi FujiiDivision of Functional Imaging, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.ORCID 0000-0001-5470-5151
Kohshin WashiyamaAdvanced Clinical Research Center, Fukushima Medical University, Fukushima 960-1295, Japan.ORCID 0000-0002-9908-8756
National Institutes for Quantum Science and Technology · JPNational Cancer Center Hospital East · JPToho University · JPFukushima Medical University · JP

Funding

Japan Agency for Medical Research and Development JP20cm0106279s0101Tohoku University 202012-RDKGE-0007
6 · The paper itself

Abstract

Actinium-225 (

Indexed as

aminopolycarboxylate chelatorsfree 225Actargeted alpha therapyunexpected radiation exposure

Identifiers

PMID34683999
PMCPMC8540721
OpenAlexW3207612728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.